NEW YORK, June 18, 2013 (GLOBE NEWSWIRE) -- Context Matters announces the addition of Dr. Paul Greenberg to its Board of Advisors.
"The addition of Paul to our Board of Advisors brings significant additional expertise across the areas of medicine, entrepreneurship, managed care and the world of healthcare data," said Yin Ho, MD, MBA, founder and CEO of Context Matters. "Based on his experience with Fingertip Formulary, Medco Health and MedPage Today, as well as his connections within the industry, we look forward to working closely with Paul as we continue to develop our market and product development strategies."
"Context Matters is doing a great job of aggregating and simplifying the access to complex data sets within the pharmaceutical and biotech industry," said Dr. Greenberg. "I am very excited to join the team as an advisor."
Currently a partner and founder of JuMP Health Ventures, Paul Greenberg is an entrepreneur, investor, and physician executive with expertise in managed care, the healthcare data, and eCommerce. Prior to launching JuMP Health Ventures, Paul founded Fingertip Formulary, which revolutionized the way pharmaceutical companies access and use managed care data. Fingertip, which was sold to Decision Resources Group, provides highly intuitive, web-based platforms that offer real-time data solutions for pharmaceutical companies. Paul was also a founder and president of MedPage Today, a leading physician website, currently owned by Everyday Health, that offers real-time breaking medical news and CME. He previously held various positions at Medco Health in eCommerce and business development.
Paul received his M.D. from Mount Sinai School of Medicine with a distinction in research. He completed a residency in internal medicine at Massachusetts General Hospital and a gastroenterology fellowship at UCSF. He was graduated from Wesleyan University, in Middletown, Connecticut and is an alumnus of the Fieldston School in New York City.
Context Matters offers a unique and innovative data-driven software platform which allows customers and users to understand the risk and value of their products by accessing complex data that has never before been quantified or aggregated in a manner designed to answer the most pertinent questions facing the pharma/biotech industry today.